16-1984260-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000248114.7(GFER):āc.42C>Gā(p.Asn14Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000879 in 1,478,450 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N14T) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000248114.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFER | NM_005262.3 | c.42C>G | p.Asn14Lys | missense_variant | 1/3 | ENST00000248114.7 | NP_005253.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFER | ENST00000248114.7 | c.42C>G | p.Asn14Lys | missense_variant | 1/3 | 1 | NM_005262.3 | ENSP00000248114 | P1 | |
GFER | ENST00000561710.1 | c.3C>G | p.Asn1Lys | missense_variant | 1/2 | 2 | ENSP00000456189 | |||
GFER | ENST00000569451.1 | c.42C>G | p.Asn14Lys | missense_variant | 1/2 | 5 | ENSP00000456432 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152040Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000452 AC: 6AN: 1326410Hom.: 0 Cov.: 32 AF XY: 0.00000306 AC XY: 2AN XY: 653758
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152040Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74258
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.42C>G (p.N14K) alteration is located in exon 1 (coding exon 1) of the GFER gene. This alteration results from a C to G substitution at nucleotide position 42, causing the asparagine (N) at amino acid position 14 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with GFER-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 14 of the GFER protein (p.Asn14Lys). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at